Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 7/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 6/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | NCK1 | P16333 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA9 | Q16790 | 3/20 | 0.32 |
| ▸ | NQO2 | P16083 | 1/20 | 0.32 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16001627 | 0.86 | CYP1A2 (0.54) | CYP1A2CYP2A6LMNAALDH1A1KDM4E | |
| SCHEMBL607927 | 0.80 | CYP1A2 (0.71) | CYP1A2CYP2A6LMNAALDH1A1KDM4E | |
| SCHEMBL597341 | 0.78 | CYP1A2 (0.67) | CYP1A2CYP2A6LMNAALDH1A1KDM4E | |
| SCHEMBL598308 | 0.73 | CYP1A2 (0.60) | CYP1A2CYP2A6LMNAALDH1A1KDM4E | |
| SCHEMBL16871332 | 0.73 | MAOB (0.41) | LMNAALDH1A1KDM4EGAAHPGD | |
| SCHEMBL20809388 | 0.72 | CYP1A2 (0.52) | CYP1A2CYP2A6LMNAALDH1A1KDM4E | |
| SCHEMBL12769101 | 0.72 | CYP1A2 (0.52) | CYP1A2CYP2A6LMNAALDH1A1KDM4E | |
| SCHEMBL14924812 | 0.72 | CYP1A2 (0.46) | CYP1A2CYP2A6LMNAALDH1A1KDM4E | |
| SCHEMBL9473298 | 0.72 | CYP1A2 (0.65) | CYP1A2CYP2A6LMNAALDH1A1KDM4E | |
| SCHEMBL26330826 | 0.72 | CYP1A2 (0.57) | CYP1A2CYP2A6LMNAALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9493394-B2 | Photoaligning materials | ROLIC AG (CH) | 2016-11-15 | — | — | US | disclosed |
| US-9334366-B2 | Photoaligning materials | ROLIC AG (CH) | 2016-05-10 | — | — | US | disclosed |
| US-20140342086-A1 | PHOTOALIGNING MATERIALS | ROLIC AG (CH) | 2014-11-20 | — | — | US | disclosed |
| US-20140249244-A1 | PHOTOALIGNING MATERIALS | ROLIC AG (CH) | 2014-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140249244-A1 | PHOTOALIGNING MATERIALS | LCP1, PIN1, MAP1LC3C | CYP1A2 3934/4885CYP2A6 4501/4885LMNA 796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.